Matthew S Karafin1,2, Shibani Dogra3, Mark Rodeghier4, Marie Burdick5, Borna Mehrad5, C Edward Rose5, Robert M Strieter6, Michael R DeBaun7, Robert C Strunk8, Joshua J Field1,3. 1. Medical Sciences Institute, BloodCenter of Wisconsin, Milwaukee, Wisconsin. 2. Department of Pathology, Medical College of Wisconsin, Milwaukee, Wisconsin. 3. Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin. 4. Independent Statistician, Chicago, Illinois. 5. Department of Medicine, University of Virginia, Charlottesville, Virginia. 6. Novartis Institutes for Biomedical Research, Cambridge, Massachusetts. 7. University School of Medicine and Monroe Carell Jr Children's Hospital, Nashville, Tennessee. 8. Department of Pediatrics, Washington University School of Medicine, St. Louis, Missouri.
Abstract
BACKGROUND: Interstitial lung disease is common in patients with sickle cell anemia (SCA). Fibrocytes are circulating cells implicated in the pathogenesis of pulmonary fibrosis and airway remodeling in asthma. In this study, we tested the hypotheses that fibrocyte levels are: (1) increased in children with SCA compared to healthy controls, and (2) associated with pulmonary disease. PROCEDURE: Cross-sectional cohort study of children with SCA who participated in the Sleep Asthma Cohort Study. RESULTS: Fibrocyte levels were obtained from 45 children with SCA and 24 controls. Mean age of SCA cases was 14 years and 53% were female. In children with SCA, levels of circulating fibrocytes were greater than controls (P < 0.01). The fibrocytes expressed a hierarchy of chemokine receptors, with CXCR4 expressed on the majority of cells and CCR2 and CCR7 expressed on a smaller subset. Almost half of fibrocytes demonstrated α-smooth muscle actin activation. Increased fibrocyte levels were associated with a higher reticulocyte count (P = 0.03) and older age (P = 0.048) in children with SCA. However, children with increased levels of fibrocytes were not more likely to have asthma or lower percent predicted forced expiratory volume in 1 sec/forced vital capacity (FEV1 /FVC) or FEV1 than those with lower fibrocyte levels. CONCLUSIONS: Higher levels of fibrocytes in children with SCA compared to controls may be due to hemolysis. Longitudinal studies may be able to better assess the relationship between fibrocyte level and pulmonary dysfunction.
BACKGROUND:Interstitial lung disease is common in patients with sickle cell anemia (SCA). Fibrocytes are circulating cells implicated in the pathogenesis of pulmonary fibrosis and airway remodeling in asthma. In this study, we tested the hypotheses that fibrocyte levels are: (1) increased in children with SCA compared to healthy controls, and (2) associated with pulmonary disease. PROCEDURE: Cross-sectional cohort study of children with SCA who participated in the Sleep Asthma Cohort Study. RESULTS: Fibrocyte levels were obtained from 45 children with SCA and 24 controls. Mean age of SCA cases was 14 years and 53% were female. In children with SCA, levels of circulating fibrocytes were greater than controls (P < 0.01). The fibrocytes expressed a hierarchy of chemokine receptors, with CXCR4 expressed on the majority of cells and CCR2 and CCR7 expressed on a smaller subset. Almost half of fibrocytes demonstrated α-smooth muscle actin activation. Increased fibrocyte levels were associated with a higher reticulocyte count (P = 0.03) and older age (P = 0.048) in children with SCA. However, children with increased levels of fibrocytes were not more likely to have asthma or lower percent predicted forced expiratory volume in 1 sec/forced vital capacity (FEV1 /FVC) or FEV1 than those with lower fibrocyte levels. CONCLUSIONS: Higher levels of fibrocytes in children with SCA compared to controls may be due to hemolysis. Longitudinal studies may be able to better assess the relationship between fibrocyte level and pulmonary dysfunction.
Authors: Borna Mehrad; Marie D Burdick; David A Zisman; Michael P Keane; John A Belperio; Robert M Strieter Journal: Biochem Biophys Res Commun Date: 2006-12-11 Impact factor: 3.575
Authors: M E Yeager; C M Nguyen; D D Belchenko; K L Colvin; S Takatsuki; D D Ivy; K R Stenmark Journal: Eur Respir J Date: 2011-06-23 Impact factor: 16.671
Authors: Roderick J Phillips; Marie D Burdick; Kurt Hong; Marin A Lutz; Lynne A Murray; Ying Ying Xue; John A Belperio; Michael P Keane; Robert M Strieter Journal: J Clin Invest Date: 2004-08 Impact factor: 14.808
Authors: Robert C Strunk; Stanley J Szefler; Brenda R Phillips; Robert S Zeiger; Vernon M Chinchilli; Gary Larsen; Kevin Hodgdon; Wayne Morgan; Christine A Sorkness; Robert F Lemanske Journal: J Allergy Clin Immunol Date: 2003-11 Impact factor: 10.793
Authors: Borna Mehrad; Marie D Burdick; Nancy J Wandersee; Kaushik S Shahir; Liyun Zhang; Pippa M Simpson; Robert M Strieter; Joshua J Field Journal: Blood Adv Date: 2017-11-06